{
  "name": "BioMarkIQ",
  "website": "https://www.biomarkiq.com",
  "updated": "2026-10-17",
  "facts": [
    {
      "id": "company-direction",
      "statement": "BioMarkIQ is developing biomarker panels and machine learning for earlier cancer detection, one disease at a time.",
      "context": "Development direction; no clinical performance or availability claim.",
      "updated": "2026-10-16"
    },
    {
      "id": "lung-focus",
      "statement": "VarSee Lung is BioMarkIQ’s initial lung-cancer development focus.",
      "context": "Does not establish clinical availability, approval, or performance.",
      "updated": "2026-10-16"
    },
    {
      "id": "moe-direction",
      "statement": "BioMarkIQ’s mixture-of-experts approach connects specialist machine-learning models through contextual gating.",
      "context": "Conceptual architecture; not a claim about a deployed model or evaluated performance.",
      "updated": "2026-10-16"
    },
    {
      "id": "research-stage",
      "statement": "VarSee Lung is available for research use only. Not for diagnostic use.",
      "context": "Research-use availability only; no diagnostic use, regulatory approval, or performance claim.",
      "updated": "2026-10-16"
    }
  ]
}